Chase AIPricingFAQs
Display currency
Loading news…

Xvivo Perfusion

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Göteborg, Vastra Gotaland, Sweden Founded 1998 101-250 employees For Profit

XVIVO Perfusion develops optimized solutions for organ, tissue, and cell preservation in connection with transplantation.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
2
Monthly Visits
Available in Pro
Contacts
49

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
IT spend
$1000K

Company Info

Founded
1998
Employees
101-250
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
57
HQ
Göteborg, Vastra Gotaland, Sweden
Region
European Union (EU), Nordic Countries, Scandinavia

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
2.9
Trend (90d)
-0.6
Last leadership hire
Jan 28, 2025

Acquisitions by Xvivo Perfusion

Loading columns…
0 of 0Show
Page 1 / 1
49
professional contacts at Xvivo Perfusion
Contact execs at Xvivo Perfusion

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Xvivo Perfusion

Loading news…

FAQs about Xvivo Perfusion

People who checked this page also checked these

Sectors Xvivo Perfusion invests & acquires in

M&A by year

Browse the full Acquirezy directory.
Xvivo Perfusion - Company Profile, Full Acquisitions List, Funding and Investments